Home › Funds › Alyeska Investment Group, L.P. › BIIB

Alyeska Investment Group, L.P. position in BIIB

BIOGEN INC · Health Care

Alyeska Investment Group, L.P. reported holding 932,374 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$201.4M, representing 0.52% of its reported portfolio and ranking #37 among its reported holdings. Alyeska Investment Group, L.P. has disclosed BIIB holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)932.37K sh
Reported value held$201.45M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alyeska Investment Group, L.P.'s BIIB position evolved

Alyeska Investment Group, L.P. first disclosed a stake in BIIB in Q3 2023 at 442,076 shares (US$113.6M). The position peaked in Q2 2026 at 932,374 shares, worth US$201.4M. Across 9 filings, Alyeska Investment Group, L.P. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 932,374 shares valued at US$201.4M — an increase of 127,324 shares quarter over quarter.. Notable position changes include a 61% trim in Q1 2024 (shares rose 8% over the following quarter), a 141% increase in Q2 2024 (shares fell 16% over the following quarter), a 66% increase in Q3 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 442.08K $113.62M New
Q4 2023 422.68K $109.38M Reduce
Q1 2024 166.69K $35.94M Reduce
Q2 2024 401.00K $92.96M Add
Q2 2025 508.77K $63.90M New
Q3 2025 845.28K $118.41M Add
Q4 2025 1.02M $180.26M Add
Q1 2026 805.05K $147.59M Reduce
Q2 2026 932.37K $201.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Alyeska Investment Group, L.P. held BIIB?

Alyeska Investment Group, L.P. has disclosed BIIB holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Alyeska Investment Group, L.P.'s current position in BIIB?

As of Q2 2026, Alyeska Investment Group, L.P. holds 932.37K shares of BIIB (BIOGEN INC), valued at $201.45M, representing 0.52% of its reported portfolio and ranking #37.

Has Alyeska Investment Group, L.P. been buying or selling BIIB?

In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. increased its position in BIIB. The position peaked in Q2 2026 at 932.37K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.